Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors

Sivgin, Serdar; Karakuş, Esen; Keklik, MUZAFFER; ZARARSIZ, GÖKMEN; Solmaz, Musa; Kaynar, LEYLAGÜL; Eser, BÜLENT; Cetin, MUSTAFA; Unal, ALİ

doi:10.1016/j.transci.2016.03.003

Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors

Sivgin S., Karakuş E., Keklik M., ZARARSIZ G., Solmaz M., Kaynar L., ...More

TRANSFUSION AND APHERESIS SCIENCE, vol.54, no.3, pp.410-415, 2016 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 54 Issue: 3
Publication Date: 2016
Doi Number: 10.1016/j.transci.2016.03.003
Journal Name: TRANSFUSION AND APHERESIS SCIENCE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.410-415
Keywords: Allogeneic hematopoietic stem cell transplantation, Stem cell mobilization, G-CSF, Biosimilars
Erciyes University Affiliated: Yes

Abstract

Objectives and Aim: In this study, we aimed to compare the potency of different G-CSF agents including original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) on CD34(+) cell mobilization in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT).